Zobrazeno 1 - 4
of 4
pro vyhledávání: '"T N, Yiğenoğlu"'
Autor:
S, Seçilmiş, D, İskender, B A, Candır, E, Bozan, S, Yaman, B U, Ulu, T N, Yiğenoğlu, M K, Çakar, M S, Dal, F, Altuntaş
Publikováno v:
European review for medical and pharmacological sciences. 26(10)
Heavy menstrual bleeding (HMB) is the most common cause of iron deficiency anemia (IDA) in premenopausal women. Clinical studies have shown that iron carboxymaltose (ICM) is an appropriate, effective, and well-tolerated treatment option for clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5ac58748ad9077fb3d0cd2091d59ee4a
https://pubmed.ncbi.nlm.nih.gov/35647829
https://pubmed.ncbi.nlm.nih.gov/35647829
Autor:
D, İskender, M, İbanoğlu, S, Seçilmiş, N A, Baysal, M K, Çakar, M S, Dal, B U, Ulu, S Y, Ergani, A, Kaymak, T T, İlhan, S, Başçı, T N, Yiğenoğlu, C, İskender, F, Altuntaş
Publikováno v:
European review for medical and pharmacological sciences. 26(3)
This study was conducted to retrospectively investigate the pregnancy outcomes of patients who underwent stem cell transplantation (SCT). We also aimed at determining the reasons for avoiding pregnancy despite prolonged remission.The study population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a0939809fbac6fb56e48d6d4a436f4b
https://pubmed.ncbi.nlm.nih.gov/35179765
https://pubmed.ncbi.nlm.nih.gov/35179765
Autor:
D, İskender, M K, Çakar, M S, Dal, N A, Baysal, A, Merdin, M, Bakırtas, B U, Ulu, S, Başcı, T N, Yiğenoğlu, F, Altuntaş
Publikováno v:
European review for medical and pharmacological sciences. 26(3)
The aim of the present study was to compare the effects of nivolumab bridge to allogeneic hematopoietic stem cell transplantation (allo-SCT) on progression-free survival (PFS) and overall survival (OS) and toxicity profile.The study population consis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1bdac1c7939b24211150f80f81fd02e0
https://pubmed.ncbi.nlm.nih.gov/35179762
https://pubmed.ncbi.nlm.nih.gov/35179762
Autor:
J, Yildiz, B U, Ulu, T N, Yiğenoğlu, S, Başçı, T, Darçın, M, Bakırtaş, D, Şahin, H, Batgi, A, Merdin, N A, Baysal, D, İskender, M K, Çakar, M S, Dal, F, Altuntaş
Publikováno v:
European review for medical and pharmacological sciences. 25(10)
Although the clinical features and treatment results of Hodgkin lymphoma (HL) in young adults are well known, it is thought that the disease may have different characteristics in elderly patients with HL, which constitutes almost 25% of the group. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::645e37ab4ad6d55beb3fe1c9a49ab8c1
https://pubmed.ncbi.nlm.nih.gov/34109574
https://pubmed.ncbi.nlm.nih.gov/34109574